The blockade of cyclooxygenases-1 and -2 reduces the effects of hypoxia on endothelial cells

Brazilian Journal of Medical and Biological Research

Volumn 39, Issue 9, 2006, Pages 1189-1196

  Gloria, M A ^a   Cenedeze, M A ^a   Pacheco Silva, A ^a   Câmara, Niels O S ^a,b  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Cyclooxygenase; Endothelial cell; Heme oxygenase 1; Hypoxia; Indomethacin

Indexed keywords

ACRIDINE ORANGE; CHEMOKINE; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; DYE; ETHIDIUM BROMIDE; HEME OXYGENASE 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INDOMETACIN; LACTATE DEHYDROGENASE; MESSENGER RNA; OXYGEN; PROSTAGLANDIN SYNTHASE INHIBITOR; RANTES;

ANIMAL CELL; ARTICLE; CELL FUNCTION; CELL HYPOXIA; CELL IMMORTALIZATION; CELL VIABILITY; CONTROLLED STUDY; ENDOTHELIUM CELL; ENDOTHELIUM INJURY; ENZYME ACTIVITY; ENZYME INHIBITION; GAS EXCHANGE; MOUSE; NONHUMAN; OXYGEN TENSION; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; PROTEIN SYNTHESIS INHIBITION; QUANTITATIVE ANALYSIS; UPREGULATION;

EID: 33750000105     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2006000900006     Document Type: Article

References (33)

1. Thadhani R, Pascual M, Bonventre JV. Acute renal failure. N Engl J Med 1996; 334: 1448-1460.
2. Perico N, Cattaneo D, Sayegh MH, Remuzzi G. Delayed graft function in kidney transplantation. Lancet 2004; 364: 1814-1827.
3. Ojo AO, Wolfe RA, Held PJ, Port FK, Schmouder RL. Delayed graft function: risk factors and implications for renal allograft survival. Transplantation 1997; 63: 968-974.
4. Takada M, Chandraker A, Nadeau KC, Sayegh MH, Tilney NL. The role of the B7 costimulatory pathway in experimental cold ischemia/reperfusion injury. J Clin Invest 1997; 100: 1199-1203.
5. Berria N, Arnuld T, Remacle J, Michiels C. Hypoxia-induced increase in intracellular calcium concentration in endothelial cells: role of the Na(+)-glucose cotransporter. J Cell Biochem 2001; 84: 115-131.
6. Kawai T, Seki M, Hiromatsu K, Eastcott JW, Watts GF, Sugai M, et al. Selective diapedesis of Th1 cells induced by endothelial cell RANTES. J Immunol 1999; 163: 3269-3278.
7. Taub DD, Conlon K, Lloyd AR, Oppenheim JJ, Kelvin DJ. Preferential migration of activated CD4+ and CD8+ T cells in response to MIP-1 alpha and MIP-1 beta. Science 1993; 260: 355-358.
8. DeWitt DL. Prostaglandin endoperoxide synthase: regulation of enzyme expression. Biochim Biophys Acta 1991; 1083: 121-134.
9. Wei Z, Costa K, Al-Mehdi AB, Dodia C, Muzykantov V, Fisher AB. Simulated ischemia in flow-adapted endothelial cells leads to generation of reactive oxygen species and cell signaling. Circ Res 1999; 85: 682-689.
10. Domoki F, Veltkamp R, Thrikawala N, Robins G, Bari F, Louis TM, et al. Ischemia-reperfusion rapidly increases COX-2 expression in piglet cerebral arteries. Am J Physiol 1999; 277: H1207-H1214.
11. Feitoza CQ, Sanders H, Cenedeze M, Camara NO, Pacheco-Silva A. Pretreatment with indomethacin protects from acute renal failure following ischemia-reperfusion injury. Transplant Proc 2002; 34: 2979-2980.
12. Feitoza CQ, Camara NO, Pinheiro HS, Goncalves GM, Cenedeze MA, Pacheco-Silva A, et al. Cyclooxygenase 1 and/or 2 blockade ameliorates the renal tissue damage triggered by ischemia and reperfusion injury. Int Immunopharmacol 2005; 5: 79-84.
13. Camara NO, Soares MP. Home oxygenase-1 (HO-1), a protective gene that prevents chronic graft dysfunction. Free Radic Biol Med 2005; 38: 426-435.
14. Lee JW, Bae SH, Jeong JW, Kim SH, Kim KW. Hypoxia-inducible factor (HIF-1)alpha: its protein stability and biological functions. Exp Mol Med 2004; 36: 1-12.
15. Zagorska A, Dulak J. HIF-1: the knowns and unknowns of hypoxia sensing. Acta Biochim Pol 2004; 51: 563-585.
16. Mazure NM, Brahimi-Horn MC, Berta MA, Benizri E, Bilton RL, Dayan F, et al. HIF-1: master and commander of the hypoxic world. A pharmacological approach to its regulation by siRNAs. Biochem Pharmacol 2004; 68: 971-980.
17. de Souza Durao M Jr, Razvickas CV, Goncalves EA, Okano IR, Camargo SM, Monte JC, et al. The role of growth factors on renal tubular cells submitted to hypoxia and deprived of glucose. Ren Fail 2003; 25: 341-353.
18. Bonnekoh B, Farkas B, Geisel J, Mahrle G. Lactate dehydrogenase release as an indicator of dithranol-induced membrane injury in cultured human keratinocytes. A time profile study. Arch Dermatol Res 1990; 282: 325-329.
19. Simon LS. Role and regulation of cyclooxygenase-2 during inflammation. Am J Med 1999; 106: 37S-42S.
20. Kim SH, Lee SM. Expression of hepatic vascular stress genes following ischemia/reperfusion and subsequent endotoxemia. Arch Pharm Res 2004; 27: 769-775.
21. Otterbein LE, Soares MP, Yamashita K, Bach FH. Home oxygenase-1: unleashing the protective properties of heme. Trends Immunol 2003; 24: 449-455.
22. Otterbein LE, Zuckerbraun BS, Haga M, Liu F, Song R, Usheva A, et al. Carbon monoxide suppresses arteriosclerotic lesions associated with chronic graft rejection and with balloon injury. Nat Med 2003; 9: 183-190.
23. Yamashita K, McDaid J, Ollinger R, Tsui TY, Berberat PO, Usheva A, et al. Biliverdin, a natural product of heme catabolism, induces tolerance to cardiac allografts. FASEB J 2004; 18: 765-767.
24. Parfenova H, Neff RA III, Alonso JS, Shlopov BV, Jamal CN, Sarkisova SA, et al. Cerebral vascular endothelial home oxygenase: expression, localization, and activation by glutamate. Am J Physiol Cell Physiol 2001; 281: C1954-C1963.
25. Quan S, Yang L, Shnouda S, Jiang H, Balazy M, Schwartzman ML, et al. Functional expression of human heme oxygenase-1 (HO-1) driven by HO-1 promoter in vitro and in vivo. J Cell Biochem 2002; 85: 410-421.
26. Haider A, Olszanecki R, Gryglewski R, Schwartzman ML, Lianos E, Kappas A, et al. Regulation of cyclooxygenase by the heme-heme oxygenase system in microvessel endothelial cells. J Pharmacol Exp Ther 2002; 300: 188-194.
27. Ejima K, Perrella MA. Alteration in heme oxygenase-1 and nitric oxide synthase-2 gene expression during endotoxemia in cyclooxygenase-2-deficient mice. Antioxid Redox Signal 2004; 6: 850-857.
28. Quan S, Yang L, Shnouda S, Schwartzman ML, Nasjletti A, Goodman AI, et al. Expression of human home oxygenase-1 in the thick ascending limb attenuates angiotensin II-mediated increase in oxidative injury. Kidney Int 2004; 65: 1628-1639.
29. Vicente AM, Guillin MI, Alcaraz MJ. Participation of home oxygenase-1 in a model of acute inflammation. Exp Biol Med 2003; 228: 514-516.
30. Li Volti G, Seta F, Schwartzman ML, Nasjletti A, Abraham NG. Heme oxygenase attenuates angiotensin II-mediated increase in cyclooxygenase-2 activity in human femoral endothelial cells. Hypertension 2003; 41: 715-719.
31. Fernandez P, Guillen MI, Gomar F, Aller E, Molina P, Alcaraz MJ. A novel cyclo-oxygenase-2 inhibitor modulates catabolic and antiinflammatory mediators in osteoarthritis. Biochem Pharmacol 2004; 68: 417-421.
32. Andoh Y, Suzuki H, Araki M, Mizutani A, Ohashi T, Okumura T, et al. Low- and high-level expressions of heme oxygenase-1 in cultured cells under uninduced conditions. Biochem Biophys Res Commun 2004; 320: 722-729.
33. Takeda K, Lin J, Okubo S, Kazawa-Kudoh S, Kajinami K, Kanemitsu S, et al. Transient glucose deprivation causes upregulation of heme oxygenase-1 and cyclooxygenase-2 expression in cardiac fibroblasts. J Mol Cell Cardiol 2004; 36: 821-830.